Review Article
Drug-Eluting Stents in Multivessel Coronary Artery Disease: Cost Effectiveness and Clinical Outcomes
Table 1
Death and repeat revascularization at five years with CABG and stenting.
| Study Name | CABG versus Stenting | Rate of repeat revascularization | Death |
| ERACI-II | 7.2% versus 28.4%, P = 0.0002 | 11.5% versus 7.1%, P = 0.182 | ARTS | 8.8% versus 30.3%, | 7.6% versus 8.0%; P = 0.83 | SOS | 6.0% versus 20.7%, * | 4.3% versus 8.1%; P = 0.016 |
|
|
*Clinical outcomes at median followup of 02 years.
|